BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38474281)

  • 1. Functional
    Wang CM; Tan KP; Wu YJ; Zheng JW; Wu J; Chen JY
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the MICA polymorphism in systemic lupus erythematosus.
    Yoshida K; Komai K; Shiozawa K; Mashida A; Horiuchi T; Tanaka Y; Nose M; Hashiramoto A; Shiozawa S
    Arthritis Rheum; 2011 Oct; 63(10):3058-66. PubMed ID: 21702010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of the association between functional MICA-TM polymorphisms and systemic lupus erythematosus, rheumatoid arthritis and ankylosing spondylitis.
    Lee YH; Bae SC; Kim JH; Song GG
    Z Rheumatol; 2015 Mar; 74(2):146-52. PubMed ID: 25060517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple Myeloma.
    Zingoni A; Vulpis E; Cecere F; Amendola MG; Fuerst D; Saribekyan T; Achour A; Sandalova T; Nardone I; Peri A; Soriani A; Fionda C; Mariggiò E; Petrucci MT; Ricciardi MR; Mytilineos J; Cippitelli M; Cerboni C; Santoni A
    Front Immunol; 2018; 9():926. PubMed ID: 29765374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Concentrations of Circulating Soluble MHC Class I-Related Chain A (sMICA) and sMICB and Modulation of Plasma Membrane MICA Expression: Potential Mechanisms and Correlation With Natural Killer Cell Activity in Systemic Lupus Erythematosus.
    Hervier B; Ribon M; Tarantino N; Mussard J; Breckler M; Vieillard V; Amoura Z; Steinle A; Klein R; Kötter I; Decker P
    Front Immunol; 2021; 12():633658. PubMed ID: 34012432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA class II, MICA and PRL gene polymorphisms: the common contribution to the systemic lupus erythematosus development in Czech population.
    Fojtíková M; Novota P; Cejková P; Pešičková S; Tegzová D; Cerná M
    Rheumatol Int; 2011 Sep; 31(9):1195-201. PubMed ID: 20352225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MICA and NKG2D variants as risk factors in spondyloarthritis: a case-control study.
    Fechtenbaum M; Desoutter J; Delvallez G; Brochot E; Guillaume N; Goëb V
    Genes Immun; 2019 Sep; 20(7):599-605. PubMed ID: 30177859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of MICA-129 polymorphism and circulating soluble MICA level with rheumatoid arthritis in a south Indian Tamil population.
    Mariaselvam CM; Boukouaci W; Charron D; Krishnamoorthy R; Tamouza R; Misra DP; Negi VS
    Int J Rheum Dis; 2018 Mar; 21(3):656-663. PubMed ID: 28752674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major histocompatibility complex class I chain-related gene A polymorphism and linkage disequilibrium with HLA-B alleles in Euro-Brazilians.
    Ribas F; Oliveira LA; Petzl-Erler ML; Bicalho MG
    Tissue Antigens; 2008 Dec; 72(6):532-8. PubMed ID: 19000131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo expression pattern of MICA and MICB and its relevance to auto-immunity and cancer.
    Schrambach S; Ardizzone M; Leymarie V; Sibilia J; Bahram S
    PLoS One; 2007 Jun; 2(6):e518. PubMed ID: 17565371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MICA polymorphisms and decreased expression of the MICA receptor NKG2D contribute to idiopathic pulmonary fibrosis susceptibility.
    Aquino-Galvez A; Pérez-Rodríguez M; Camarena A; Falfan-Valencia R; Ruiz V; Montaño M; Barrera L; Sada-Ovalle I; Ramírez R; Granados J; Pardo A; Selman M
    Hum Genet; 2009 Jun; 125(5-6):639-48. PubMed ID: 19363685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants in NKG2D axis and susceptibility to Epstein-Barr virus-induced nasopharyngeal carcinoma.
    Viet NH; Trung NQ; Dong LT; Trung LQ; Espinoza JL
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):713-723. PubMed ID: 33392659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of an NKG2D gene variant with systemic lupus erythematosus in two populations.
    Kabalak G; Thomas RM; Martin J; Ortego-Centeno N; Jimenez-Alonso J; de Ramón E; Buyny S; Hamsen S; Gross WL; Schnarr S; Zeidler H; Gromnica-Ihle E; Schmidt RE; Witte T
    Hum Immunol; 2010 Jan; 71(1):74-8. PubMed ID: 19735685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Donor Major Histocompatibility Complex Class I Chain-Related Molecule A Allele rs2596538 G Predicts Cytomegalovirus Viremia in Kidney Transplant Recipients.
    Rohn H; Tomoya Michita R; Schwich E; Dolff S; Gäckler A; Trilling M; Le-Trilling VTK; Wilde B; Korth J; Heinemann FM; Horn PA; Kribben A; Witzke O; Rebmann V
    Front Immunol; 2018; 9():917. PubMed ID: 29867932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of MICA with rheumatoid arthritis independent of known HLA-DRB1 risk alleles in a family-based and a case control study.
    Kirsten H; Petit-Teixeira E; Scholz M; Hasenclever D; Hantmann H; Heider D; Wagner U; Sack U; Hugo Teixeira V; Prum B; Burkhardt J; Pierlot C; Emmrich F; Cornelis F; Ahnert P
    Arthritis Res Ther; 2009; 11(3):R60. PubMed ID: 19409079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms.
    Melum E; Karlsen TH; Schrumpf E; Bergquist A; Thorsby E; Boberg KM; Lie BA
    Hepatology; 2008 Jan; 47(1):90-6. PubMed ID: 18023027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of NKG2D gene variants with susceptibility and severity of rheumatoid arthritis.
    Mariaselvam CM; Tamouza R; Krishnamoorthy R; Charron D; Misra DP; Jain VK; Negi VS
    Clin Exp Immunol; 2017 Mar; 187(3):369-375. PubMed ID: 27783394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A GPI anchor explains the unique biological features of the common NKG2D-ligand allele MICA*008.
    Ashiru O; López-Cobo S; Fernández-Messina L; Pontes-Quero S; Pandolfi R; Reyburn HT; Valés-Gómez M
    Biochem J; 2013 Sep; 454(2):295-302. PubMed ID: 23772752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-λ3/4 genetic variants and interferon-λ3 serum levels are biomarkers of lupus nephritis and disease activity in Taiwanese.
    Chen JY; Wang CM; Chen TD; Jan Wu YJ; Lin JC; Lu LY; Wu J
    Arthritis Res Ther; 2018 Aug; 20(1):193. PubMed ID: 30157968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus.
    Gambelunghe G; Gerli R; Bocci EB; Del Sindaco P; Ghaderi M; Sanjeevi CB; Bistoni O; Bini V; Falorni A
    Rheumatology (Oxford); 2005 Mar; 44(3):287-92. PubMed ID: 15522921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.